OncoCyte Corporation (OCX) declined -8.24% or -0.14 to $1.56. It is near to 10752 shares traded, which is 31.63% compare to the average total volume 33998. The market cap of OCX is $63.44 million. The year to date change is -71.28%. The 52 week price range is from $1.1 to $6.45. Price of OCX have changed 0.59% during last week. It have changed -15.00% over last month, -29.17% over last 3 months, -38.18% over last 6 months and -66.99% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for OCX is 1.96. It is 25.64% above current price. The 200-day Moving Averages for OCX is 2.37. It is 51.92% above current price. The 52-week High is 6.45. It is 313.46% from the current price. The 52-week Low is 1.1. It is -29.49% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of OCX is 9.54 on 2018-11-15. Short % to float is 1.10%. There are some statistics of OCX. It is has market cap $63.44 million. The share outstanding is 40.66 million. The average volume is 33998. The percent of top 15 Institution holding is 23.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of OCX is -196.45%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of OCX is -112.66%.